Table 2 Baseline characteristics of study patients based on the level of MMP9 in the constrictive pericardium
From: Predictive value of matrix metalloprotease 9 on surgical outcomes after pericardiectomy
Variables | MMP9-low group (N = 11) | MMP9-high group (N = 11) | P value |
|---|---|---|---|
Gender | |||
Male | 11 (100%) | 11 (100%) | |
Age, years | 70 (54–80) | 73 (54–80) | 0.270 |
Etiology | – | ||
Tuberculosis | 11 (100%) | 11 (100%) | |
Preoperative NYHA functional class | 0.327 | ||
I | 2 (18.2%) | 0 (0%) | |
II | 1 (9.1%) | 3 (27.3%) | |
III | 8 (72.7%) | 8 (72.7%) | |
Hypertension | 1 (9.1%) | 2 (18.2%) | 1.000 |
Diabetes | 2 (18.2%) | 2 (18.2%) | 1.000 |
Heart disease* | 2 (18.2%) | 4 (36.4%) | 0.635 |
BMI, kg/m2 | 21.3 (17.3–24.8) | 21.0 (17.7–24.8) | 0.652 |
Pulse rate, beats/min | 98 (80–112) | 90 (80–145) | 0.699 |
Preoperative CVP, cmH2O | 23.0 (20.5–30.0) | 30.0 (20.4–42.5) | 0.065 |
Pericardial thickness, mm | 10.7 (8.2–16.0) | 10.7 (7.0–16.0) | 0.847 |
LVEF, % | 54.3 (50.0–56.4) | 56.0 (51.9–64.0) | 0.101 |
CRP, mg/L | 11.7 (5.0–21.0) | 17.0 (5.0–62.5) | 0.076 |
ESR, mm/h | 37.0 (3.0–52.0) | 37.0 (17.0–68.0) | 0.300 |